MANAGEMENT OF RETINAL HEMANGIOBLASTOMA IN VON HIPPEL-LINDAU DISEASE

To review the current state of diagnosis and management of retinal hemangioblastoma and retinal vascular proliferation arising from von Hippel-Lindau (VHL) disease. A review of the literature was performed. Consensus was reached among authors regarding current practice, with reference to published d...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Retina (Philadelphia, Pa.) Ročník 39; číslo 12; s. 2254
Hlavní autori: Wiley, Henry E, Krivosic, Valerie, Gaudric, Alain, Gorin, Michael B, Shields, Carol, Shields, Jerry, Aronow, Mary E, Chew, Emily Y
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 01.12.2019
Predmet:
Hemangioblastoma - diagnosis
Hemangioblastoma - therapy
Humans
Retinal Neoplasms - diagnosis
Retinal Neoplasms - therapy
Retinal Vessels - pathology
von Hippel-Lindau Disease - diagnosis
ISSN:1539-2864, 1539-2864
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Popis
Shrnutí:To review the current state of diagnosis and management of retinal hemangioblastoma and retinal vascular proliferation arising from von Hippel-Lindau (VHL) disease. A review of the literature was performed. Consensus was reached among authors regarding current practice, with reference to published data where possible. von Hippel-Lindau disease and its ocular manifestations are relatively rare, and there is limited evidence in the literature on which to base management. There was consensus on core principles, including 1) recognition and diagnosis of von Hippel-Lindau disease when present, with appropriate referral for care of this potentially lethal systemic condition; 2) regular ophthalmic evaluation for individuals with von Hippel-Lindau disease, to identify and offer timely treatment for new or active retinal hemangioblastomas; 3) ablative treatment of retinal hemangioblastomas that can be safely destroyed, to lower risk of vision loss; 4) observation or consideration of nonablative treatments for retinal hemangioblastomas that cannot be safely destroyed; and 5) observation of asymptomatic retinal vascular proliferation, with consideration of vitrectomy for lesions exerting effects on vision. Ocular outcomes can be gratifying in many cases with appropriate management. Improved understanding of the molecular basis for the disease creates an opportunity for rational design of better therapies.
Bibliografia:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ISSN:1539-2864
1539-2864
DOI:10.1097/IAE.0000000000002572